NanoString Technologies has launched three new products for the nCounter Analysis System: the Immuno-Oncology RNA:Protein Profiling Panel; the PanCancer Progression Panel; and the PanCancer Mouse Immune Profiling Panel.
The Immuno-Oncology RNA:Protein Profiling Panel is a single assay that enables simultaneous measurement of up to 800 RNA and protein targets in minute cancer samples. It is based on the company's PanCancer Immune Profiling panel, which measures 770 RNA and 30 proteins important in immuno-oncology research. NanoString said that this product will initially be available to select customers through an early-access program.
The PanCancer Progression Panel, now available to all customers, addresses key questions about what happens when cancer metastasizes, and includes genes for the study of angiogenesis, epithelial mesenchymal transition, extracellular matrix formation, and metastasis.
The PanCancer Mouse Immune Profiling Panel provides researchers with a tool for pre-clinical immuno-oncology studies.